Biological Therapeutic Products

Conferences & Courses
ImVacS ImVacS
August 13-16, 2012 | Cambridge, MA
The Immunotherapeutics & Vaccine Summit - ImVacS, presents three meetings that address today' s breakthroughs and persistent challenges for developing and manufacturing vaccines in an open, collegial environment.

Novel Vaccines Novel Vaccines
August 13-15, 2012 | Cambridge, MA

Vaccine Quality throughout the Life Cycle Vaccine Quality throughout the Life Cycle
August 13-14, 2012 | Cambridge, MA
CHI's Production & Manufacturing of Vaccines conference, August 16-18, 2011, will discuss the field of vaccine and immunotherapeutic manufacturing.




Life Science Media Library
Harnessing CHO Cells DVD Harnessing CHO Cells DVD
January 10, 2012 |
Escherichia coli has proven its worth as a protein expression platform. Currently, E.coli is not viewed so much as an ‘alternative’ platform, but as a viable choice for achieving high-level expression of human genes and proteins at a reasonable cost.
Characterization Techniques for Protein Therapeutics DVD Characterization Techniques for Protein Therapeutics DVD
May 12, 2011 |
This DVD covers the progression of “creating a best of breed informatics organization” from the basics of biology and genetics to application of semantic technologies. Through modeling, case studies, and best practice examples, participants will learn techniques on how to combine data in a meaningful way.




Publications, Reports, & Whitepapers
Cloud Computing Usage in Biotech & Pharma Market Study 	Cloud Computing Usage in Biotech & Pharma Market Study
Insight Pharma Reports conducted a targeted industry survey on therapeutic cancer vaccines, which was designed to focus on standardized immunogenic vaccines vs. autologous cell therapies or passive immunotherapies. Here, we present our survey findings concerning the future outlook of the cancer vaccine industry.
Cancer Vaccines Market Study Cancer Vaccines Market Study
Insight Pharma Reports conducted a targeted industry survey on therapeutic cancer vaccines, which was designed to focus on standardized immunogenic vaccines vs. autologous cell therapies or passive immunotherapies. Here, we present our survey findings concerning the future outlook of the cancer vaccine industry.
New Trends in Preventive and Therapeutic Vaccines 	New Trends in Preventive and Therapeutic Vaccines
New Trends in Preventive and Therapeutic Vaccines: R&D Activities and Commercial Prospects, published by Insight Pharma Reports provides an analytical snapshot of the current state of the vaccine industry, its development efforts, and an outlook to 2020.














05.17.12
Featured Articles

Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.

Hosp Pract (Minneap). 2012 Feb;40(1):35-43

Authors: Lutz MA, Lovato P, Cuesta G

Abstract
OBJECTIVES: In Nicaragua, 30% of curre





Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.

Hosp Pract (Minneap). 2012 Feb;40(1):24-34

Authors: Lutz MA, Lovato P, Cuesta G

Abstract
O